July 8, 2025: The Big Ten Cancer Research Consortium is excited to announce registration is now open for the 2025 Big Ten CRC Summit on Friday, September 12, from 7:30 a.m. to 2:15 p.m. CT at the Big Ten Conference Headquarters in Rosemont, Ill.

Hosted by Penn State Cancer Institute, this year’s summit will bring together staff from our member institutions, cancer center leaders, basic scientists involved in drug discovery and translational research, industry professionals, medical science liaisons, and patient advocates.

The program will feature research highlights from across the consortium, discussions on current clinical trials and collaborative initiatives, dedicated time for networking, and recognition of important contributions to oncology research and advocacy.

Registration is free for faculty, staff, researchers, and fellows from Big Ten CRC member institutions, as well as for patient advocates. Industry attendees are welcome to register at a starting rate of $1,500 per company, which includes in-person attendance for up to two attendees. Companies interested in additional opportunities, such as a pipeline presentation, commercial booth, or lunch sponsorship, are invited to contact Jonathan Ang at jang@hoosiercancer.org for more information.

Accommodations are available at the DoubleTree by Hilton near the summit venue.

To view the agenda and register, please visit https://bigtencrc.org/summit/

About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow. Since its founding, the Big Ten CRC has activated nearly 40 clinical trials across a wide range of cancer types, more than 1,000 participants have enrolled in Big Ten CRC studies, and more than 500 researchers have joined Big Ten CRC Clinical Trial Working Groups. 

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 18 Big Ten institutions provide direct financial support for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women. For more information, visit www.bigten.org.